Insulet sales grow 22% in Q1

Insulet (NSDQ:PODD) topped estimates on Wall Street yesterday with its first-quarter results, topping analysts’ sales expectations by $1.9 million. The Billerica, Mass.-based company reeled in its losses, posting a net loss of -$6.6 million, or -11¢ per share, on sales of $123.6 million for the 3 months ended March 31, for bottom-line growth of 34.2% on sales growth of 21.5% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Insulet sales grow 22% in Q1 appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Insulet Source Type: news